Archive for April 10th, 2012

TRGT fails trial after revised data. ARQL offering. OMER initiates second Phase 3 trial

Apr 10, 2012 No Comments by

Targacept, Inc. (NASDAQ: TRGT) announced revised top-line results from its Phase 2 trial of TC-6987 in asthma which showed that it no longer reached the co-primary endpoint as it revealed a 2 ml decrease in the change in Forced Expiratory Volume (FEV) from baseline to pre-dosing on day 28. It continued to meet the other co-primary endpoint, change […]

Daily News Read more

Upcoming FDA and clinical catalysts as of April 10 2012

Apr 10, 2012 No Comments by

Some short and long term potential catalysts as of April 9, 2012 (share prices as at the close of trading Monday, April 9, 2012). See the links in the FDA Calendar for more details about each catalyst. The possible catalysts listed below represent both short and long opportunities. It is NOT a recommendation to take […]

Catalysts Read more